A 4-Week, Two-Center, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of EOPatch in Well-Controlled Type 1 Diabetes Mellitus

This study evaluated the safety and efficacy of tubeless patch pump called EOPatch in patients with well-controlled type 1 diabetes mellitus (T1DM). This 4-week, two-center, open-label, single-arm study enrolled 10 adult patients diagnosed with T1DM with glycosylated hemoglobin less than 7.5%. The c...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jiyun, Park, Nammi, Han, Sangjin, Lee, You-Bin, Kim, Gyuri, Jin, Sang-Man, Lee, Woo Je, Kim, Jae Hyeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723198/
https://www.ncbi.nlm.nih.gov/pubmed/35255546
http://dx.doi.org/10.4093/dmj.2021.0299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723198/
https://www.ncbi.nlm.nih.gov/pubmed/35255546
http://dx.doi.org/10.4093/dmj.2021.0299

Ejemplares similares